The ESCRS feels that financial interest should not restrict the information presented at its meetings, provided that appropriate disclosure of any interest is made. All presenters must disclose any financial interest in the subject matter of their presentation. Presenters will be required to state their interest on the title slide of their presentation. Financial interest will also be indicated in the Final Programme.
If you have any financial interest in the subject matter that you will present, you are required to include the relevant reference numbers at the end of your abstract. If more than one of the categories below applies to you, please indicate all categories e.g. Financial Disclosure: 1,9
Category |
Description |
Ref. No. |
| Product |
Author gains financially from product or procedure presented |
1 |
| |
Author gains financially from competing product or procedure |
2 |
| Employee |
Author is employed by a for-profit company with an interest in the subject of the presentation |
3 |
| |
Author is employed by a competing company |
4 |
| Investor |
Author has significant investment interest in a company producing, developing or supplying product or procedure presented |
5 |
| |
Author has significant investment interest in a competing company |
6 |
| Consultant |
If any of the situations below apply to the author within the past 12 months they must be disclosed |
| |
Author receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented |
7 |
| |
Author receives consulting fees, retainer, or contract payments from a competing company |
8 |
| |
Author's research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented |
9 |
| |
Author's research is funded, fully or partially, by a competing company |
10 |
| |
Author's travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented |
11 |
| |
Author's travel has been funded, fully or partially, by a competing company |
12 |
| |
Author receives non-monetary benefits from a company producing, developing or supplying the product or procedure presented. |
13 |
| |
Author receives non-monetary benefits from a competing company. |
14 |
COURSE INFORMATION 
